Clinical and laboratory aspects of thyroid autoantibodies

Annals of Clinical Biochemistry

Volumn 43, Issue 3, 2006, Pages 173-183

  Sinclair, David ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR;

ANTIBODY RESPONSE; ANTIGEN BINDING; AUTOIMMUNE DISEASE; BREAST CANCER; CELL MEDIATED CYTOTOXICITY; CELL SURFACE; CLINICAL FEATURE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IODINATION; LABORATORY TEST; PATHOPHYSIOLOGY; PATIENT MONITORING; PERNICIOUS ANEMIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SJOEGREN SYNDROME; THYROID DISEASE; THYROID FOLLICLE CELL; URTICARIA;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; IODIDE PEROXIDASE; RECEPTORS, THYROTROPIN; THYROGLOBULIN; THYROID DISEASES;

EID: 33646356474     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456306776865043     Document Type: Review

References (101)

1. Hashimoto H. Zur Kenntnis der lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa). Arch Klin Chir Berlin 1912; 97: 219-48
2. Graves RJ. Newly observed affection of the thyroid gland in females (clinical lectures) Lond Med Surg J 1835; VII: 516-7
3. and reprinted in 'Medical Classics' 1940; 5: 33-6
4. Mark H, Beers MD, Robert Berkow MD, eds. http://www.merck.com/mrkshared/mm_geriatrics/sec8/ch65.jsp
5. Duntas LH. Subclinical thyroid disorders: the menace of the Trojan horse. J Endocrinol Invest 2003; 26: 472-80
6. Weetman AP. New aspects of thyroid immunity. Horm Res 1997; 48: 51-4
7. Dunn JT, Ray SC. Variations in the structure of thyroglobulins from normal and goitrous human thyroids. J Clin Endocrinol Metab 1978; 47: 861-9
8. Okosieme OE, Parkes AB, Premawardhana LD, Evans C, Lazarus JH. Thyroglobulin: current aspects of its role in autoimmune thyroid disease and thyroid cancer. Minerva Med 2003; 94: 319-30
9. McLachlan SM, Rapoport B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid 2004; 14: 510-20
10. Lisi S, Marino M, Pinchera A, et al. Thyroglobulin in orbital tissues from patients with thyroid-associated ophthalmopathy: predominant localization in fibroadipose tissue. Thyroid 2002; 12: 351-60
11. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 1998; 19: 673-716
12. Tahara K, Ishikawa N, Yamamoto K, et al. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Thyroid 1997; 7: 867-77
13. Chazenbalk GD, Latrofa F, McLachlan SM, Rapoport B. Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit. J Clin Endocrinol Metab 2004; 89: 1788-93
14. Minich WB, Lenzner C, Morgenthaler NG. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Clin Exp Immunol 2004; 136: 129-36
15. McLachlan SM, Rapoport B. The molecular biology of thyroid peroxidase: Cloning, expression, and role as autoantigen in autoimmune thyroid disease. Endocr Rev 1992; 13: 192-206
16. Portmann L, Hamada N, Heinrich G, DeGroot LJ. Antithyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J Clin Endocrinol Metab 1985; 61: 1001-3
17. Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 1985; 190: 147-52
18. Rapoport B, McLachlan SM. Thyroid autoimmunity. J Clin Invest 2001; 108: 1253-9
19. Khoury EL, Hammond L, Bottazzo GF, Doniach D. Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin Exp Immunol 1981; 45: 316-28
20. Jaume JC, Guo J, Pauls DL, et al. Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic 'fingerprints'. J Clin Endocrinol Metab 1999; 84: 1424-31
21. - symporter in the sera of patients with autoimmune thyroid disease. Biochem Biophys Res Commun 1996; 224: 92-5
22. Heufelder AE, Joba W, Morgenthaler NG. Autoimmunity involving the human sodium/iodide symporter: fact or fiction? Exp Clin Endocrinol Diab 2001; 109: 35-40
23. Seissler J, Wagner S, Schott M, et al. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85: 4630-4
24. Katakura M, Yamada T, Aizawa T, et al. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease. J Clin Endocrinol Metab 1987; 64: 405-8
25. Marino M, Chiovato L, Friedlander JA, Latrofa F, Pinchera A, McCluskey RT. Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis. J Clin Endocrinol Metab 1999; 84: 2468-74
26. Hofman LF, Foley TP, Henry JJ, Naylor EW. The use of filter paper-dried blood spots for thyroid-antibody screening in adults. J Lab Clin Med 2004; 144: 307-12
27. Shenkman L, Bottone EJ. Antibodies to Yersinia enterocolitica in thyroid disease. Ann Intern Med 1976; 85: 735-9
28. Resetkova E, Notenboom R, Arreaza G, Mukuta T, Yoshikawa N, Volpe R. Seroreactivity to bacterial antigens is not a unique phenomenon in patients with autoimmune thyroid diseases in Canada. Thyroid 1994; 4: 269-74
29. Ruf J, Feldt-Rasmussen U, Hegedus L, Ferrand M, Carayon P. Bispecific thyroglobulin and thyroperoxidase autoantibodies in patients with various thyroid and autoimmune diseases. J Clin Endocrinol Metab 1994; 79: 1404-9
30. Groves CJ, Howells RD, Williams S, Darke C, Parkes AB. Primary standardisation of the ELISA of serum thyroid peroxidase and thyroglobulin antibodies and their prevalence in a normal Welsh population. J Clin Lab Immunnol 1991; 32: 147-51
31. Massart C, Maugendre D. Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves disease. Clin Chem 2002; 48: 102-7
32. Southgate K, Creagh FM, Teece M, Kingswood C, Rees Smith B. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol 1984; 20: 539-43
33. Shewring G, Rees-Smith B. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol 1982; 17: 409-17
34. Feldt-Rasmussen U. Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin and thyrotropin receptor. Clin Chem 1996; 42: 160-3
35. Brix T, Kyvik KO, Hegedüs L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 2000; 85: 536-9
36. Brix TH, Kyvik KO, Christensen K, Hegedüs L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001; 86: 930-4
37. Brix TH, Kyvik KO, Hegedüs L. What is the evidence of genetic factors in the etiology of Graves' disease? A brief review. Thyroid 1998; 8: 727-34
38. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003; 24: 694-717
39. Hall R, Owen SG, Smart GA. Evidence for genetic predisposition to formation of thyroid auto-antibodies. Lancet 1960; 2: 187-8
40. Phillips D, Prentice L, Upadhyaya M, et al. Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin - studies in families not selected for autoimmune thyroid disease. J Clin Endocrinol Metab 1991; 72: 973-5
41. Phillips DIW, Shields DC, Dougoujon JM, Prentice L, McGuffin P, Rees Smith B. Complex segregation analysis of thyroid autoantibodies: are they inherited as an autosomal dominant trait? Hum Hered 1993; 43: 141-6
42. Yanagawa T, Mangklabruks A, Chang Y-B, et al. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1993; 76: 1569-74
43. Stenszky V, Kozma L, Balázs C, Rochlitz S, Bear JC, Farid NR. The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 1985; 61: 735-40
44. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 2003; 24: 694-717
45. Eheman CR, Garbe P, Tuttle RM. Autoimmune thyroid disease associated with environmental thyroidal irradiation. Thyroid 2003; 13: 453-64
46. Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003; 148: 1-9
47. Giordano C, Stassi G, De Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960-3
48. Arscott PL, Baker Jr JR. Apoptosis and thyroiditis. Clin Immunol Immunopathol 1998; 87: 207-17
49. Weetman AP, De Groot LJ. Autoimmunity to the thyroid. www.thyroidmanager.org/thyroidbook.htm
50. Spencer CA. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab 2004; 89: 3702-4
51. Feldt-Rasmussen U, Hoier-Madsen M, Bech K, et al. Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. Autoimmunity 1991; 9: 245-54
52. Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol 2003; 58: 38-40
53. Hjiyiannakis P, Mundy J, Harmer C. Thyroglobulin antibodies in differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 1999; 11: 240-4
54. Chiovato L, Latrofa F, Braverman LE, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003; 139: 346-51
55. Baloch Z, Carayon P, Conte-Devolx B, et al. (Guidelines Committee, National Academy of Clinical Biochemistry). Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3-126
56. Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol 2003; 58: 38-40
57. Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 1121-7
58. Khoo DH, Ho SC, Seah LL, et al. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 1999; 9: 1175-80
59. Goh SY, Ho SC, Seah LL, Fong KS, Khoo DH. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol 2004; 60: 600-7
60. Irvine WJ, Davies SH, Teitelbaum S, Delamore IW, Williams AW. The clinical and pathological significance of gastric parietal cell antibody. Ann N Y Acad Sci 1965; 124: 657-91
61. Doniach D, Roitt IM, Taylor KB. Autoimmune phenomena in pernicious anemia. Serological overlap with thyroiditis, thyrotoxicosis, and systemic lupus erythematosus. BMJ 1963; 5342: 134-9
62. 12 in hypothyroidism. Lancet 1962; 1: 703-6
63. Punzi L, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 2004; 71: 275-283
64. Mulhern LM, Masi AT, Shulman LE. Hashimoto's disease. A search for associated disorders in 170 clinically detected cases. Lancet 1966; 2: 508-11
65. Morita H, Arima T, Matsuda M. Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid diseases. J Clin Endocrinol Metab 1995; 80: 1203-6
66. Pyne D, Isenberg DA. Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 2002; 61: 70-2
67. Stagi S, Giani T, Simonini G, Falcini F. Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis. Rheumatology 2005 (Epub ahead of print)
68. Smyth PPA, Kilbane MT, Murray MJ, Mc Dermott EWM, Smith DF, O'Higgins NJ. Serum thyroid peroxidase autoantibodies, thyroid volume and outcome in breast cancer. Clin Endocr Metab 1988; 83: 2711-6
69. Smyth PPA. Autoimmune thyroid disease and breast cancer: a chance association. J Endocrinol Invest 2000; 23: 42-3
70. Levy Y, Segal N, Weintrob N, Danon YL. Chronic urticaria: association with thyroid autoimmunity. Arch Dis Child 2003; 88: 517-9
71. Verneuil L, Leconte C, Ballet JJ, Coffin C, Laroche D, Izard JP. Association between chronic urticaria and thyroid autoimmunity: a prospective study involving 99 patients. Dermatology 2004; 208: 98-103
72. Counsell CE, Taha A, Ruddell WS. Coeliac disease and autoimmune thyroid disease. Gut 1994; 35: 844-6
73. Volta U, Ravaglia G, Granito A, et al. Coeliac disease in patients with autoimmune thyroiditis. Digestion 2001; 64: 61-5
74. Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C. The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatr 2004; 4: 25
75. Janssen OE, Mehlmauer N, Hahn S, Offner AH, Gartner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004; 150: 363-9
76. Stagnaro-Green A, Glinoer D. Thyroid autoimmunity and the risk of miscarriage. Best Pract Res Clin Endocrinol Metab 2004; 18: 67-81
77. Sieiro Netto L, Medina Coeli C, Micmacher E, et al. Influence of thyroid autoimmunity and maternal age on the risk of miscarriage. Am J Reprod Immunol 2004; 52: 312-6
78. Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur J Endocrinol 2004; 150: 751-5
79. Takeoka K, Hidaka Y, Hanada H, et al. Increase in serum levels of autoantibodies after attack of seasonal allergic rhinitis in patients with Graves' disease. Int Arch Allergy Immunol 2003; 132: 268-76
80. Guma M, Salinas I, Reverter JL, et al. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J Clin Endocrinol Metab 2003; 88: 2141-6
81. Jenkins RC, Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid 2002; 12: 975-86
82. Zophel K, Saller B, Wunderlich G, et al. Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: implications for the definition of TPOAb reference intervals. Clin Lab 2003; 49: 591-600
83. Lazarus JH, Parkes AB, Premawardhana LD. Postpartum thyroiditis. Autoimmunity 2002; 35: 169-73
84. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol 1995; 43: 55-68
85. Cooper DS. Subclinical hypothyroidism. N Engl J Med 2001; 345: 260-5
86. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-38
87. Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism: the Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. BMJ 1996; 313: 539-44
88. American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457-69
89. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 1995; 273: 808-12
90. Berry P. Audit of investigation of subclinical hypothyroidism in Scottish laboratories. Ann Clin Biochem 2002; 39: 26-33
91. Briston P, Sinclair D. Antibodies to thyroid peroxidase (TPOAb) in serum from patients with slightly raised thyrotropin (TSH) levels. Clin Lab 2004; 50: 383-6
92. Lock RJ, Marden NA, Kemp HJ, Thomas PH, Goldie DJ, Gompels MM. Subclinical hypothyroidism: a comparison of strategies to achieve adherence to treatment guidelines. Ann Clin Biochem 2004; 41: 197-200
93. Spencer CA. Assay of Thyroid Hormones and Related Substances. http://www.thyroidmanager.org/FunctionTests/assay-text.htm
94. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 1999; 175: 336-9
95. Daniels GH. Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 2001; 86: 3-8
96. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin N Am 2001; 30: 315-37
97. Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999; 84: 90-7
98. Kumar H, Daykin J, Betteridge J, Holder R, Sheppard MC, Franklyn JA. Prevalence and clinical usefulness of thyroid antibodies in different disease states of the thyroid. Clin Endocrinol 1999; 50: 679-80
99. Guerin B, Vautier V, Boin-Gay V, Estrade G, Choulot JJ, Doireau V. Severe neonatal hyperthyroidism which reveals a maternal Graves' disease. Ann Endocrinol 2004; 65: 25-30
100. Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998; 139: 584-6
101. Clark PM, Beckett G. Can we measure serum thyroglobulin? Ann Clin Biochem 2002; 39: 196-202